Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

First indication of the effect of COVID-19 vaccinations on the course of the outbreak in Israel

View ORCID ProfileH. De-Leon, R. Calderon-Margalit, View ORCID ProfileF. Pederiva, View ORCID ProfileY. Ashkenazy, View ORCID ProfileD. Gazit
doi: https://doi.org/10.1101/2021.02.02.21250630
H. De-Leon
1INFN-TIFPA Trento Institute of Fundamental Physics and Applications, Via Sommarive, 14, 38123 Povo TN, Italy
2European Centre for Theoretical Studies in Nuclear Physics and Related Areas (ECT*), Strada delle Tabarelle 286, I-38123 Villazzano (TN), Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for H. De-Leon
  • For correspondence: hdeleon@ectstar.eu
R. Calderon-Margalit
3Hebrew University-Hadassah Braun School of Public Health, 9112102, Jerusalem, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. Pederiva
1INFN-TIFPA Trento Institute of Fundamental Physics and Applications, Via Sommarive, 14, 38123 Povo TN, Italy
4Dipartimento di Fisica, University of Trento, via Sommarive 14, I–38123, Povo, Trento, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for F. Pederiva
Y. Ashkenazy
5Racah Institute of Physics, The Hebrew University of Jerusalem, 9190401 Jerusalem, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Y. Ashkenazy
D. Gazit
5Racah Institute of Physics, The Hebrew University of Jerusalem, 9190401 Jerusalem, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for D. Gazit
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Concomitantly with rolling out its rapid COVID-19 vaccine program, Israel is experiencing its third, and so far largest, surge in morbidity. We aimed to estimate whether the high vaccine coverage among individuals aged over 60 years old creates an observable change in disease dynamics. Using observed and simulated data, we suggest that the shape of the outbreak as measured by daily new moderate and severe cases, and in particular of patients aged over 60, has changed because of vaccination, bringing the decline in new moderate and severe cases earlier than expected, by about a week. Our analyses is consistent with the assumption that vaccination lead to higher than 50% protection in preventing clinical disease and with at least some effectiveness in blocking transmission of elderly population, and supports the importance of prioritizing vulnerable population. This is the first indication of the effectivity of COVID-19 vaccine in changing the course of an ongoing pandemic outbreak.

One Sentence Summary We show, by data analysis and modelling of the dynamics of COVID-19 pandemic in Israel, that the current nationwide outbreak, that had up to 0.1% of the population confirmed daily, is clearly affected by the vaccination program, that reached a coverage of more than 80% among people ≥ 60 years old.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No external funding was received

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study protocol was approved by the Institutional Review Board (Helsinki Committee) of Hadassah Medical Center. Study was exempted from informed consent based on anonymity of participants (anonymization carried out by the Ministry of Health) and aggregated data analysis.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data that support the findings of this study are available from the corresponding author upon reasonable request: * Most of the data is available on https://data.gov.il/dataset/covid-19 * Daily moderate and severe cases by age groups were obtained from the Ministry of Health. Data provided by the Ministry of Health was available through the Ministry's research room, accessible only to authorized researchers (Ronit Calderon-Margalit). Data was then aggregated by age and analyzed in two age groups and without any identifiers.

https://t.me/MOHreport/7485

https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2020/Ausgaben/17_20.pdf%20?__blob=publicationFile

https://data.gov.il/dataset/covid-19

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted February 03, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
First indication of the effect of COVID-19 vaccinations on the course of the outbreak in Israel
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
First indication of the effect of COVID-19 vaccinations on the course of the outbreak in Israel
H. De-Leon, R. Calderon-Margalit, F. Pederiva, Y. Ashkenazy, D. Gazit
medRxiv 2021.02.02.21250630; doi: https://doi.org/10.1101/2021.02.02.21250630
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
First indication of the effect of COVID-19 vaccinations on the course of the outbreak in Israel
H. De-Leon, R. Calderon-Margalit, F. Pederiva, Y. Ashkenazy, D. Gazit
medRxiv 2021.02.02.21250630; doi: https://doi.org/10.1101/2021.02.02.21250630

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (557)
  • Anesthesia (135)
  • Cardiovascular Medicine (1769)
  • Dentistry and Oral Medicine (238)
  • Dermatology (173)
  • Emergency Medicine (316)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (662)
  • Epidemiology (10812)
  • Forensic Medicine (8)
  • Gastroenterology (594)
  • Genetic and Genomic Medicine (2960)
  • Geriatric Medicine (288)
  • Health Economics (534)
  • Health Informatics (1933)
  • Health Policy (836)
  • Health Systems and Quality Improvement (745)
  • Hematology (293)
  • HIV/AIDS (633)
  • Infectious Diseases (except HIV/AIDS) (12525)
  • Intensive Care and Critical Care Medicine (696)
  • Medical Education (300)
  • Medical Ethics (87)
  • Nephrology (324)
  • Neurology (2808)
  • Nursing (152)
  • Nutrition (433)
  • Obstetrics and Gynecology (559)
  • Occupational and Environmental Health (597)
  • Oncology (1473)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (257)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (381)
  • Pediatrics (868)
  • Pharmacology and Therapeutics (367)
  • Primary Care Research (338)
  • Psychiatry and Clinical Psychology (2646)
  • Public and Global Health (5383)
  • Radiology and Imaging (1016)
  • Rehabilitation Medicine and Physical Therapy (597)
  • Respiratory Medicine (727)
  • Rheumatology (330)
  • Sexual and Reproductive Health (290)
  • Sports Medicine (279)
  • Surgery (327)
  • Toxicology (48)
  • Transplantation (150)
  • Urology (126)